Herceptin Research Today is a free monthly online journal that collates and summarizes the latest research about Herceptin, including details on side-effects, breast cancer, treatment, therapy.

Volume 2 (2005), Issue 4 (April)

1. A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer.
   Br J Cancer, 92(7): 1261-7. [Abstract] [Full-text]
2. Frequencies of HER-2/neu expression and gene amplification in patients with oesophageal squamous cell carcinoma.
   Br J Cancer, 92(7): 1253-60. [Abstract] [Full-text]
3. Neoadjuvant trastuzumab induces apoptosis in primary breast cancers.
   J Clin Oncol, 23(11): 2460-8. [Abstract] [Full-text]
4. Purification of cyclotron-produced 203Pb for labeling Herceptin.
   Nucl Med Biol, 32(3): 301-5. [Abstract] [Full-text]
5. Lack of trastuzumab activity in nonsmall cell lung carcinoma with overexpression of erb-B2: 39810: a phase II trial of Cancer and Leukemia Group B.
   Cancer, 103(8): 1670-5. [Abstract] [Full-text]
6. Matching of trastuzumab (Herceptin) epitope mimics onto the surface of Her-2/neu--a new method of epitope definition.
   Mol Immunol, 42(9): 1121-4. [Abstract] [Full-text]
7. The antitumor immune response in HER-2 positive, metastatic breast cancer patients.
   J Transl Med, 3(1): 13. [Abstract] [Full-text]
8. Resistance of tumor interstitial pressure to the penetration of intraperitoneally delivered antibodies into metastatic ovarian tumors.
   Clin Cancer Res, 11(8): 3117-25. [Abstract] [Full-text]
9. Growth factor regulation of a 26S proteasomal subunit in breast cancer.
   Clin Cancer Res, 11(8): 2868-74. [Abstract] [Full-text]
10. EGF receptor inhibition: attacks on multiple fronts.
    Cancer Cell, 7(4): 287-8. [Abstract] [Full-text]
11. TGFalpha expression impairs Trastuzumab-induced HER2 downregulation.
    Oncogene, 24(18): 3002-10. [Abstract] [Full-text]
12. Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma.
    J Clin Pathol, 58(5): 500-3. [Abstract] [Full-text]

© 2004-2008 Herceptin Research Today. All Rights Reserved.